Ness Ziona
Israel
38
2025-11-20
33
2026-01-06
These are the the leading inventors for applications assigned to MAPI PHARMA LTD.:
MAPI PHARMA LTD. based in Ness Ziona, IL has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
GLATIRAMER DEPOT SYSTEMS FOR TREATING PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS
#2 | 2025-04-24 ✅ Patent 12,514,908 granted on 2026-01-06SEMAGLUTIDE DEPOT SYSTEMS AND USE THEREOF
#3 | 2024-07-18 ✅ Patent 12,251,380 granted on 2025-03-18Depot systems comprising cariprazine or salts thereof
#4 | 2024-05-09SEMAGLUTIDE DEPOT SYSTEMS AND USE THEREOF
#5 | 2023-09-21 ✅ Patent 11,931,357 granted on 2024-03-19Depot systems comprising Cariprazine or salts thereof
#6 | 2023-08-17LOW BURST-RELEASE LIRAGLUTIDE DEPOT SYSTEMS
#7 | 2023-01-19 ✅ Patent 11,865,213 granted on 2024-01-09Semaglutide depot systems and use thereof
#8 | 2023-01-05 ✅ Patent 12,097,292 granted on 2024-09-24Process for preparing microparticles containing glatiramer acetate
#9 | 2022-01-27 ✅ Patent 12,343,371 granted on 2025-07-01GLATIRAMER DEPOT SYSTEMS FOR TREATING PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS
#10 | 2021-09-30 ✅ Patent 11,471,421 granted on 2022-10-18Process for preparing microparticles containing glatiramer acetate
#11 | 2021-09-16 ✅ Patent 12,370,233 granted on 2025-07-29DEPOT SYSTEMS COMPRISING GLATIRAMER ACETATE
#12 | 2021-08-26EXTENDED RELEASE DOSAGE FORMS OF PREGABALIN
#13 | 2021-07-22 ✅ Patent 12,161,688 granted on 2024-12-10Treatment of inflammatory bowel disease with long acting glatiramer and adipose-derived stem cells
#14 | 2020-12-03 ✅ Patent 11,167,003 granted on 2021-11-09Methods for suppressing or alleviating primary or secondary progressive multiple sclerosis (PPMS or SPMS) using sustained release glatiramer depot systems
#15 | 2020-05-14 ✅ Patent 11,413,311 granted on 2022-08-16Treatment of multiple sclerosis with long acting glatiramer and adipose-derived stem cells
#16 | 2019-10-03 ✅ Patent 11,026,908 granted on 2021-06-08Extended release dosage forms of pregabalin
#17 | 2018-01-11 ✅ Patent 10,111,867 granted on 2018-10-30Process and intermediates for the preparation of perampanel
#18 | 2017-06-22 ✅ Patent 9,994,522 granted on 2018-06-12Amorphous form of apremilast
#19 | 2017-03-23 ✅ Patent 10,493,122 granted on 2019-12-03Sublingual delivery of glatiramer acetate
#20 | 2016-12-08 ✅ Patent 9,617,241 granted on 2017-04-11Intermediate compounds and process for the preparation of efinaconazole
#21 | 2015-05-28 ✅ Patent 9,453,024 granted on 2016-09-27Polymorphs of darunavir
#22 | 2015-02-19 ✅ Patent 9,102,592 granted on 2015-08-11Intermediate compounds and processes for the preparation of quinoline derivatives such as laquinimod sodium
#23 | 2014-12-18 ✅ Patent 9,096,574 granted on 2015-08-04Polymorphs of perampanel
#24 | 2014-11-27 ✅ Patent 9,206,197 granted on 2015-12-08Amorphous form of dolutegravir
#25 | 2014-11-20 ✅ Patent 9,006,188 granted on 2015-04-14Co-crystals of dapagliflozin
#26 | 2014-08-14PROCESS AND INTERMEDIATES FOR THE PREPARATION OF SUBSTITUTED 2-ARYLTHIAZOLE CARBOXYLIC ACIDS
#27 | 2014-06-26 ✅ Patent 8,981,095 granted on 2015-03-17Intermediate compounds and process for the preparation of lurasidone and salts thereof
#28 | 2014-06-05 ✅ Patent 8,975,244 granted on 2015-03-10Process and intermediates for the preparation of abiraterone acetate
#29 | 2013-09-19 ✅ Patent 8,865,742 granted on 2014-10-21Intermediate compounds and processes for the preparation of quinoline derivatives such as Laquinimod sodium
#30 | 2013-08-22 ✅ Patent 8,735,627 granted on 2014-05-27Intermediate compounds and process for the preparation of fingolimod
#31 | 2013-06-20 ✅ Patent 9,200,114 granted on 2015-12-01Random pentapolymer for treatment of autoimmune diseases
#32 | 2013-01-24 ✅ Patent 8,921,415 granted on 2014-12-30Polymorphs of darunavir
#33 | 2012-11-22 ✅ Patent 8,829,208 granted on 2014-09-09Process for the preparation of darunavir and darunavir intermediates
#34 | 2012-11-08 ✅ Patent 8,410,176 granted on 2013-04-02Intermediate compounds and processes for the preparation of tapentadol and related compounds
#35 | 2012-09-27 ✅ Patent 8,772,503 granted on 2014-07-08Processes for the preparation of deferasirox, and deferasirox polymorphs
#36 | 2012-06-28 ✅ Patent 8,377,885 granted on 2013-02-19Depot systems comprising glatiramer or pharmacologically acceptable salt thereof
#37 | 2012-02-02 ✅ Patent 8,841,447 granted on 2014-09-23Process for the preparation of alogliptin
#38 | 2012-01-19 ✅ Patent 8,796,226 granted on 2014-08-05Depot systems comprising glatiramer or a pharmacologically acceptable salt thereof
Also check out MAPI PHARMA LTD.'s (Ness Ziona, Israel) applicant profile with 24 patent applications submitted.
27027 ⎘